Your browser doesn't support javascript.
loading
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
Mandala, Mario; Lorigan, Paul; De Luca, Matilde; Bianchetti, Andrea; Merelli, Barbara; Bettini, Anna Cecilia; Bonomi, Lucia; Nahm, Sharon; Vitale, Maria Grazia; Negrini, Giorgia; Di Croce, Andrea; Ascierto, Paolo Antonio; Rulli, Eliana; Tondini, Carlo Alberto.
Afiliação
  • Mandala M; Unit of Medical Oncology, University of Perugia, Perugia, Italy mario.mandala@unipg.it.
  • Lorigan P; Medical Oncology-Melanoma, The Christie Hospital NHS Trust, Manchester, UK.
  • De Luca M; Division of cancer sciences, The University of Manchester, Manchester, UK.
  • Bianchetti A; Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Lombardia, Italy.
  • Merelli B; Oncology, Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy.
  • Bettini AC; Unit of Medical Oncology, Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Bonomi L; Oncology, Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Nahm S; Oncology, Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Vitale MG; Medical Oncology-Melanoma, The Christie Hospital NHS Trust, Manchester, UK.
  • Negrini G; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Di Croce A; Oncology, Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Ascierto PA; Unit of Medical Oncology, Department of Oncology and Hematology, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Rulli E; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
  • Tondini CA; Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Lombardia, Italy.
J Immunother Cancer ; 9(2)2021 02.
Article em En | MEDLINE | ID: mdl-33593827
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article